Outlook of probable association of TGF-β1, viral load, with levels of some serum biomarkers and their role in the severity of COVID-19 in a sample of Iraqi population

https://doi.org/10.53730/ijhs.v6nS5.9927

Authors

  • Ghuroob Dalil Dhumad Ph.D., Faculty of Medicine, Microbiology Department, Al-nahrain University, Baghdad, Iraq
  • Haider Sabah Kadhim Ph.D., Faculty of Medicine, Microbiology Department, Al-nahrain University, Baghdad, Iraq
  • Haider Ahmad Shamran Ph.D., Faculty of Medicine, Microbiology Department, Al-nahrain University, Baghdad, Iraq
  • Hatem Dheyab Abed AL-Kindy Teaching Hospital, Baghdad, Iraq, Arab Board in Internal Medicine
  • Mudha Muhammad Sheat Ph.D., Faculty of Medicine, Microbiology Department, Dijla University, Baghdad, Iraq

Keywords:

SARS-CoV-2, TGF-β1, Viral load, LDH, O2 requirement, D-dimer

Abstract

The COVID-19 pandemic remains a rapidly spreading public health emergency with grave consequences. The disease is caused by infection with the severe acute respiratory syndrome coronavirus-2.The current study cohort included an Iraqi population with RT-PCR positive COVID-19 who were divided into two clinical groups: those who were discharged home well (n = 77) and those who required ICU admission/died (n = 23). Here we study, the age and sex on COVID-19 illness with biomarkers: TGF-B, Viral level, LDH, Oxygen prerequisite D-dimer, and CRP, among COVID-19 patients. Data revealed no basic influence of sex introduction on the result. Whereas age of individuals was basically higher P < 0.001 in (required ICU admition /died compared to that of well –discharge patients (38.83±11.74 a long time)). Level of TGF-β1 exposed no significant difference between the two enrolled groups link with viral load and duration. Period conversely had a positive noteworthy relationship with (D-dimer, CRP, LDH. Besides, (D-dimer, LDH, and CRP) levels were on the whole elevated on essentially ICU/admission compared to well-discharged patients group. The middle illness duration in well- released patients were 7.0 days (3-18 days) compared with nine days (6-14 days) in patients required ICU/died with  remarkable distinction.

Downloads

Download data is not yet available.

References

WHO Director-General's opening remarks at the media briefing on COVID-19: 11 March 2020. Published March 11, 2020. Accessed March 30, 2020.

Grasselli G, Pesenti A, Cecconi M. Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response. JAMA. 2020 Apr 28; 323(16):1545-1546.

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, et al . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30; 382(18):1708-1720.

SARS-CoV-2 in severe COVID-19 induces a TGF-β-dominated chronic immune response that does not target itself marta et.al Nature Communications volume 12, Article number: 1961 (2021)

Caroline Busatta Vaz de Paula , Seigo Nagashima , Vanessa Liberalesso , Mariana Collete , Felipe Paes Gomes da Silva COVID-19: Immunohistochemical Analysis of TGF-β Signaling Pathways in Pulmonary Fibrosis . Int J Mol Sci . 2021 Dec 24;23(1):168.

Rothan H.A., Byrareddy S.N. The epidemeology and pathogensis of coronavirus (COVID-19) outbreak. J. Autoimmun. 2020;109:1–4.

Tang T., Bidon M., Jaimes J.A., Whittaker G.R., Daniel S. Coronavirus membrane fusion mechanism offers a potential target for antiviral development. Antivir. Res. 2020;178:104792.

Li X., Zhu W., Fan M., Zhang J., Peng Y., et al. Dependence of SARS-CoV-2 infection on cholesterol-rich lipid raft and endosomal acidification. Comput. Struct. Biotechnol. J. 2021;19:1933–1943.

Kruglikov I.L., Scherer P.E. Caveolin-1 as a target in prevention and treatment of hypertrophic scarring. NPJ Regen. Med. 2019;4:9.

Ragab D., Salah Eldin H., Taeimah M., Khattab R., Salem R. The COVID-19 Cytokine Storm; What We Know So Far. Front. Immunol. 2020;11:1446.

Abbul K.A., Andrew H., Lichtman S.P. Imunologia Celular e Molecular. 8th ed. Elsevier; Rio de Janeiro, Brazil: 2012.

Atkinson J.J., Senior R.M. Matrix metalloproteinase-9 in lung remodeling. Am. J. Respir. Cell Mol. Biol. 2003;28:12–24. doi: 10.1165/rcmb.2002-0166TR.

C. Haoting Zhan, Haizhen Chen, Chenxi Liu, Linlin Cheng, Songxin Yan, et al. Diagnostic Value of D-Dimer in COVID-19: A Meta-Analysis and Meta-Regression. Clin Appl Thromb Hemost. 2021 Jan-Dec; 27:

Bastard P., Rosen L.B.,Zhang Q.,Michailidis E., Hoffmann H.H., et al. COVID Human Genetic Effort Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370:eabd4585.

Jose Gómez-Rial, Irene Rivero-Calle, Antonio Salas, and Federico Martinón-Torres Role of Monocytes/Macrophages in Covid-19 Pathogenesis: Implications for TherapyInfect Drug Resist. 2020; 13: 2485–2493.

Franceschi C, Campisi J. Exacerbated innate host response to SARS-CoV in aged non-human primates. J Gerontol A Biol Sci Med Sci. 2014 Jun; 69 Suppl 1:S4-9.

Ahmed N. KaftanMajid K. Hussain,1Abdulhussein A. Algenabi, et al. Predictive Value of C–reactive Protein, Lactate Dehydrogenase, Ferritin and D-dimer Levels in Diagnosing COVID-19 Patients: a Retrospective Study.Acta Inform Med. 2021 Mar;29(1):45–50.

Marnell L, Mold C, DuClos TW.C‐reactive protein: ligands, receptors, and role in inflammation. Clin Immunol. 2005;117(2):104‐111.

Nurshad Ali . Elevated level of C‐reactive protein may be an early marker to predict risk for severity of COVID‐19. J Med Virol. 2020 Jun 9 : 10.1002/jmv.26097.

Poudel A, Poudel Y, Adhikari A, Aryal BB, Dangol D, et al. (2021) D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19. PLoS ONE 16(8): e0256744

Xie J, Tong Z, Guan X, Du B, Qiu H. Clinical Characteristics of Patients Who Died of Coronavirus Disease 2019 in China. JAMA Netw Open. 2020 Apr 1; 3(4):e205619.

Qian J, Zhao L, Ye RZ, Li XJ, Liu YL. Age-dependent gender differences of COVID-19 in mainland China: comparative study. Clin Infect Dis. 2020;71(9):2488–94.

Nasiri MJ, Haddadi S, Tahvildari A, Farsi Y, Arbabi M, et al. (2020) COVID-19 Clinical Characteristics, and Sex-Specific Risk of Mortality: Systematic Review and Meta-Analysis. Front. Med. 7:459.

Mohitosh Biswasa Shawonur Rahamana Tapash Kumar Biswasb Zahirul Haquec Baharudin. Association of Sex, Age, and Comorbidities with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis. Intervirology 2021;64:36–47.

Al-Bari MAA, Hossain S, Zahan MK. Exploration of sex-specific and age-dependent COVID-19 fatality rate in Bangladesh population. World J Radiol. 2021;13(1):1-18.

Faris Lami, Hiba A R, Hanan Abdulghafoor Khaleel, Sinan Ghazi, et al. Iraq experience in handling the COVID-19 pandemic: implications of public health challenges and lessons learned for future epidemic preparedness planning, Journal of Public Health.(43): 3, 2021; Pages iii19–iii28,

Saeed BQ, Al-Shahrabi R, Bolarinwa OA (2021) Socio-demographic correlate of knowledge and practice toward COVID-19 among people living in Mosul-Iraq: A cross-sectional study. PLoS ONE 16(3): e0249310.

Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020. CDC COVID-19 Response Team. MMWR Morb Mortal Wkly Rep. 2020. 27; 69(12):343-346.

Al-Bari MAA, Hossain S, Zahan MK. Exploration of sex-specific and age-dependent COVID-19 fatality rate in Bangladesh population. World J Radiol. 2021;13(1):1-18.

https://www.cnbc.com/2020/03/27/why-coronavirus-deaths-are-higher-in-italy-spain-than-in-china.html.

Saeed BQ, Al-Shahrabi R, Bolarinwa OA (2021) Socio-demographic correlate of knowledge and practice toward COVID-19 among people living in Mosul-Iraq: A cross-sectional study. PLoS ONE 16(3): e0249310.

Abdulrahman, A., Mallah, S.I. & Alqahtani, M. COVID-19 viral load not associated with disease severity: findings from a retrospective cohort study. BMC Infect Dis 21, 688 (2021).

Lu J, Wei Z, Jiang H, et al.. Lactate dehydrogenase is associated with 28-day mortality in patients with sepsis: a retrospective observational study. J Surg Res 2018; 228:314–21.

Huang C, Wang Y, Li X, Ren L, Zhao J, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15; 395(10223):497-506.

Garg S, Kim L, Whitaker M, O'Halloran A, et al Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020.MMWR Morb Mortal Wkly Rep. 2020 Apr 17; 69(15):458-464.

Bickler, P. E., Feiner, J. R., Lipnick, M. S., Batchelder, P., MacLeod, D. B., et al(2017). Effects of acute, profound hypoxia on healthy humans: implications for safety of tests evaluating pulse oximetry or tissue oximetry performance. Anesth. Analg. 124, 146–153.

Abdu I. Alayash. The Impact of COVID-19 Infection on Oxygen Homeostasis: A Molecular Perspective Front. Physiol., 27 September 2021 . https://www.frontiersin.org/people/u/61968

Liu, W., and Li, H. (2020). COVID-19: attacks the 1-beta chain of hemoglobin and captures the porphyrin to inhibit human heme metabolism. ChemRxiv [Preprint]. doi: 10.26434/chemrxiv.11938173.v8

Read, R. (2020). Flawed methods in “attacks the 1-beta chain of hemoglobin and captures the porphyrin to inhibit human heme metabolism”. ChemRxiv [Preprint]. doi: 10.26434/chemrxiv.12120912.v2

Kulow, V. A., and Fähling, M. (2021). How to increase cellular oxygen availability in COVID-19? Acta Physiol. 5:e13724.

Liu Y, Yan LM, Wan L, Xiang TX, Le A, et al. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis. 2020;19:656–7.

Abdulrahman, A., Mallah, S.I. & Alqahtani, M. COVID-19 viral load not associated with disease severity: findings from a retrospective cohort study. BMC Infect Dis 21, 688 (2021). https://doi.org/10.1186/s12879-021-06376-1

Rao SN, Manissero D, Steele VR, Pareja J. A narrative systematic review of the clinical utility of cycle threshold values in the context of COVID-19. Infect Dis Ther. 2020;28:1–4.

Pujadas E, Chaudhry F, McBride R, Richter F, Zhao S, et al. SARS-CoV-2 viral load predicts COVID-19 mortality. Lancet Respir Med. 2020;8(9):e70.

Singanayagam A, Patel M, Charlett A, Bernal JL, Saliba V, et al. Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to may 2020. Eurosurveillance. 2020;25(32):2001483.

Argyropoulos KV, Serrano A, Hu J, Black M, Feng X, et al. Association of initial viral load in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients with outcome and symptoms. Am J Pathol. 2020;190(9):1881–7.

Caplan A, Bates KW, Brioni C, Santos A, Sabatini LM, et al. (2021) Clinical characteristics and viral load dynamics of COVID-19 in a mildly or moderately symptomatic outpatient sample. PLoS ONE 16(10): e0258970. https://doi.org/10.1371/journal.pone.0258970.

Wenyu Chen, Qinfeng Xiao, Zhixian Fang, Xiaodong Lv, et al. "Correlation Analysis between the Viral Load and the Progression of COVID-19", Computational and Mathematical Methods in Medicine, vol. 2021. https://doi.org/10.1155/2021/9926249

Ferreira-Gomes, M., Kruglov, A., Durek, P. et al. SARS-CoV-2 in severe COVID-19 induces a TGF-β-dominated chronic immune response that does not target itself. Nat Commun 12, 1961 (2021). https://doi.org/10.1038/s41467-021-22210-3.

Beller, A. et al. Specific microbiota enhances intestinal IgA levels by inducing TGF-beta in T follicular helper cells of Peyer’s patches in mice. Eur. J. Immunol. 50, 783–794 (2020).

Lee, C. G. et al. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J. Exp. Med. 194, 809–821 (2001).

Leeming, D. J. et al. Can biomarkers of extracellular matrix remodelling and wound healing be used to identify high risk patients infected with SARS-CoV-2?: lessons learned from pulmonary fibrosis. Respir. Res. 22, 38 (2021).

Akbarov, A. N., & Xabilov, D. N. U. (2021). The condition of the oral cavity in patients who have had a viral infection COVID-19. International Journal of Health & Medical Sciences, 4(4), 381-383. https://doi.org/10.21744/ijhms.v4n4.1796

Polak, S B, Van Gool, I C, Cohen, D., et al. A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression. Mod. Pathol. 33, 2128–2138 (2020).

Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). The COVID-19 pandemic. International Journal of Health Sciences, 5(2), vi-ix. https://doi.org/10.53730/ijhs.v5n2.2937

Shen W-X, Luo R-C, Wang J-Q and Chen Z-S (2021) Features of Cytokine Storm Identified by Distinguishing Clinical Manifestations in COVID-19. Front. Public Health 9:671788.

E. Wei-Xi Shen, Rong-Cheng Luo, Jing-Quan Wang and Zhe-Sheng Chen Features of Cytokine Storm Identified by Distinguishing Clinical Manifestations in COVID-19. Front. Public Health, 24 May 2021 | https://doi.org/10.3389/fpubh.2021.671788

Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–273.

Li X, Xu S, Yu M, et al. . Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol 2020; 146:110–8.

Brandon et al., 2020

Martha JW, Wibowo A, Pranata R. Prognostic value of elevated lactate dehydrogenase in patients with COVID-19: a systematic review and meta-analysis. Postgraduate Medical Journal Published Online First: 15 January 2021. doi: 10.1136/postgradmedj-2020-139542.

Published

29-06-2022

How to Cite

Dhumad, G. D., Kadhim, H. S., Shamran, H. A. ., Abed, H. D., & Sheat, M. M. (2022). Outlook of probable association of TGF-β1, viral load, with levels of some serum biomarkers and their role in the severity of COVID-19 in a sample of Iraqi population. International Journal of Health Sciences, 6(S5), 5547–5564. https://doi.org/10.53730/ijhs.v6nS5.9927

Issue

Section

Peer Review Articles